Bio-Techne Dividend
The Dividend of Bio-Techne (TECH) as of Jul 25, 2026 is 0.32 USD. In the previous year, Dividend was 0.32 USD — a change of 0.00% (lower).
Get this data via API
Financial Data API
Dividend
0.32USD
YoY
0.00%
Dividend yield
0.45 %
Last updated:
How much dividend does Bio-Techne 2026 pay?
According to the latest status from July 2026, Bio-Techne paid a total of 0.32 USD per share in dividends within the last 12 months. With the current Bio-Techne price of 71.63 USD, this corresponds to a dividend yield of 0.45 %. A dividend is paid times per year.
Bio-Techne currently offers a dividend yield of about 0.45%. The payout ratio is around 68% of earnings. The dividend has grown at 1.5% per year over the past 17 years.
Historical Bio-Techne Dividends
A dividend is paid times per year. Last year, the payout months were March, June, September and December.
| Paydate | Dividend |
|---|---|
| 6/18/2026 | 0.08USD |
| 3/13/2026 | 0.08USD |
| 12/17/2025 | 0.08USD |
| 9/18/2025 | 0.08USD |
| 6/19/2025 | 0.08USD |
| 3/14/2025 | 0.08USD |
| 12/8/2024 | 0.08USD |
| 9/19/2024 | 0.08USD |
| 6/10/2024 | 0.08USD |
| 3/9/2024 | 0.08USD |
| 12/9/2023 | 0.08USD |
| 12/8/2023 | 0.08USD |
| 9/17/2023 | 0.08USD |
| 6/12/2023 | 0.08USD |
| 3/10/2023 | 0.08USD |
| 12/10/2022 | 0.32USD |
| 9/12/2022 | 0.32USD |
| 6/13/2022 | 0.32USD |
| 3/25/2022 | 0.00USD |
| 3/10/2022 | 0.32USD |
Bio-Techne dividend history and estimates
Max
Details
Is the Bio-Techne Dividend Safe?
Bio-Techne has been increasing the dividend for 0 years.
Over the past 10 years, Bio-Techne has lowered it by an annual -12.94%.
Over a five-year period, the distribution dropped by -24.21%.
Analysts expect a Dividend Increase of 0.00% for the current fiscal year.
Bio-Techne dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Dividend Details
Understanding Bio-Techne's Dividend Distributions
Bio-Techne’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Bio-Techne's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Bio-Techne's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Bio-Techne’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Bio-Techne Stock analysis
Frequently Asked Questions about Bio-Techne stock
Over the past 12 months, Bio-Techne paid a dividend of 0.32 USD . This corresponds to a dividend yield of about 0.45 %. For the coming 12 months, Bio-Techne is expected to pay a dividend of 0.32 USD.
All Key Metrics — Bio-Techne
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth